Design of a folding inhibitor of the HIV-1 Protease
R. A. Broglia, G. Tiana, D. Provasi, F. Simona, L. Sutto, F. Vasile, M. Zanotti
Abstract
Being HIV-1-PR an essential enzyme in the viral life cycle, its inhibition can control AIDS. Because the folding of single domain proteins, like HIV-1-PR is controlled by local elementary structures (LES, folding units stabilized by strongly interacting, highly conserved amino acids) which have evolved over myriads of generations to recognize and strongly attract each other so as to make the protein fold fast, we suggest a novel type of HIV-1-PR inhibitors which interfere with the folding of the protein: short peptides displaying the same amino acid sequence of that of LES. Theoretical and experimental evidence for the specificity and efficiency of such inhibitors are presented.
Create a lesson
Related papers
TopoLIA: Topology-Inspired Latent Interaction Attention for Drug Discovery
Xiang Liu, Yiming Ren, Mustafa Hajij et al.
La-Ribo: RNA Co-Design via Geometry-Latent Flow Matching
Runze Ma, Will Hua, Shuangjia Zheng
MD-LLM-2: A Transferable Language Model of Molecular Dynamics with Physical Conditioning and Explicit Path Probabilities
Mhd Hussein Murtada, Z. Faidon Brotzakis, Michele Vendruscolo
De novo design of monoclonal and bispecific antibodies with OFAntibody
Valhalla Team
A Shortcut to Structure in AlphaFold 3
Jonathan Feldman, Jeffrey Skolnick
Mathematical Invariant-Enabled Topological Neural Networks for Molecular and Materials Property Prediction
Yiming Ren, Xiang Liu, Mustafa Hajij et al.